logo
Canada's EV Market Was Already in Trouble-Tariffs Made It Worse, Workers Say

Canada's EV Market Was Already in Trouble-Tariffs Made It Worse, Workers Say

Canada News.Net4 hours ago

Bob Pulham recalls the optimism in the air when General Motors began producing electric vans in Ingersoll, Ontario, in late 2022.
As the first BrightDrop commercial van rolled off the line at the CAMI Assembly plant, GM executives, union leaders and former prime minister Justin Trudeau touted it as a major milestone for electric vehicle production in Canada, The Canadian Press reports.
Pulham, a Unifor representative at the plant, remembers talk of increasing shifts and hiring more people to produce 50,000 such delivery vans annually by 2025.
But the sales never picked up, the plant kept slowing down the production line amid sluggish demand and the optimism slowly faded.
This April, GM announced it would idle the plant for several months and resume production in October with just one shift. Union members say about half of 1,200 workers at the plant will be gone as a result.
"I feel bad for all 600 that are being laid off. It's a horrible position to be put in," Pulham said in an interview. "It's a crazy amount of uncertainty and I think that hurts people."
The announcement came shortly after U.S. President Donald Trump imposed tariffs on Canadian-made vehicles, but a GM Canada spokesperson said the halt was directly related to lower-than-expected demand for the BrightDrop vans.
Pulham, who began working at the CAMI plant more than three decades ago, said his wife has also been laid off and is now pondering whether to go back to school or search for a new job.
Several other companies, including Honda, Stellantis, Umicore, and Ford have also delayed or scrapped their EV projects amid the slow sales growth and the ongoing trade war.
GM Canada said reducing production in Ingersoll was necessary to adjust to market demand and balance inventory.
But workers at the CAMI plant say Trump's tariffs made things even worse. They've experienced the industry's ups and downs over the decades, but say this challenge is especially difficult at a time of great economic uncertainty.
"There's a push to build (vehicles) in the U.S., and that has caused a lot of issues over here," Pulham said. "So, it's not a good situation."
View our latest digests
Mike Van Boekel, the Unifor Local 88 CAMI plant chairperson, said even though workers knew layoffs were on the horizon, the news was still shocking for many.
"It was terrible," he said. "I thought we were going to lose a shift. I was worried in the back of my mind ... and now it has come true."
GM's ambitious plan to be at the "forefront of a big wave" of electric delivery van production didn't materialize because the timing was not right, Boekel said.
He felt the company was gaining some momentum before the imposition of 25% tariffs on Canadian-made vehicles. GM had just received an order of a thousand delivery vans from the U.S. grocery chain giant Kroger, he said.
"So, it looked like we were just getting to go and all of a sudden, the tariffs came on," he said, adding that CAMI workers will still produce Kroger's vans when they return to the factory this fall.
Workers aren't the only ones feeling the pain.
The ripple effects of layoffs are a source of concern for Ingersoll Mayor Brian Petrie. The CAMI plant, which spans two million square feet, is the largest employer in the southwestern Ontario town of about 14,000 people.
Petrie said Ingersoll expects to receive $1.8 million in municipal taxes from the company this year, which is around 10% of the total levies the town is expected to collect.
"It is devastating because we're not talking about new employees here, either, these are long serving employees and ... they've had a tough road going up to that point," Petrie said in a recent interview at his office.
The federal government under Trudeau set a target of 100% zero-emission sales of light duty vehicles by 2035. Environment Minister Julie Dabrusin indicated mid June that the mandate won't be changing.
But that goal seems hard to achieve, Petrie said.
"It's honest to say that I think everybody may have misunderstood the scale of the problem that we're facing to do the EV switch," he said. "I think all of them will admit that it's been a bigger problem than they once thought."
Still, he thinks the more than $50 billion in investments that Canada has pledged since 2020 to incentivize the EV supply chain will pay off in the long term.
Some provinces, including Manitoba and Quebec, are offering rebates for electric vehicle purchases. B.C.'s rebate program, which was the longest running in the country, was paused last month. Ontario scrapped its rebate program after Premier Doug Ford's Progressive Conservatives won the election in 2018.
The federal government also halted in January its Incentives for Zero-Emission Vehicles program, which offered up to $5,000 off the cost of a new electric vehicle. Dabrusin said Ottawa intends to bring back consumer rebates for EVs, but doesn't yet know what they'll look like.
Zero-emissions vehicles represented only 8.7% of all new vehicle sales in Canada in the first quarter of 2025-a drop from 16.5% in the fourth quarter of 2024, according to data from Statistics Canada.
The sales of EVs and plug-in hybrids had steadily increased from below 1% in 2017 to 14.6% in 2024, but experts say the growth hasn't been nearly as fast as many expected.
Dan Park, CEO of online used car retailer Clutch, said EV adoption has been slower in Canada because people normally drive long distances in colder temperatures, which reduces battery life by 20 to 40% and slows down the charging speed.
"Canada is just a fundamentally harder market to have," he said. "Until technology and battery life is improved to be able to handle colder conditions, I think Canadians will just shy away from it."
Park said EVs make up only 5% of Clutch's inventory, which is tied to consumer demand.
He said consumer rebates and production subsidies "artificially propped up the market," and provincial and federal governments should instead invest in a stronger charging infrastructure to encourage more Canadians to adopt EVs.
A recent survey by consumer insights firm J.D. Power shows that only 28% of nearly 4,000 respondents said they were "very likely" or "somewhat likely" to consider an EV for their next vehicle purchase, down from 29% last year and 34$ in 2023. The survey also found that 75% of new vehicle purchasers aren't confident Canada can reach its 2035 zero-emission vehicle sales goal.
Manufacturers took note of the lacklustre interest.
Honda Canada announced in May that it's postponing a $15-billion EV project in Ontario, citing the "unexpected slowdown" in the market. Stellantis is postponing the production of an EV model of 2026 Dodge Charger Daytona R/T at its Windsor, Ont., plant as it assesses the effects of U.S. tariffs. And Ford Motor Co. said it will assemble F-Series Super Duty pickup trucks at its Oakville, Ont., plant beginning in 2026 instead of planned electric vehicle production at the site.
Despite the setbacks, Environment and Climate Change Canada said it will continue to support investments and innovations in the EV supply chain.
Canada's zero-emissions vehicle sales mandates ensure "Canadians have access to electric vehicles, which offer long-term savings for consumers," department spokesperson Hermine Landry said in a statement.
"Transportation emissions have declined to levels not seen in decades, demonstrating that we can grow our economy while also fighting climate change," Landry said. "It is important to remain focused on the fact that the real threat to the Canadian auto industry right now are the unjustified tariffs from the United States."
Overall, Canadians buy around two million new vehicles annually and the country produces approximately 1.5 million of them, according to Unifor. Autoworkers say the federal government should push for more vehicle production in Canada from manufacturers such as Kia, Hyundai, Mitsubishi and others that don't have any production footprint in the country, to offset the impact of U.S. tariffs.
"It'd be nice, (if) the government stands up for us and you know says to these big companies, 'If you want to sell here, then you need to build here as well,'" said Paul Harvey, who works as a framing team leader at CAMI.
Harvey said that although he and his wife will keep their jobs at the CAMI plant in Ingersoll, they will both have to work the same hours when production resumes on one shift. With four children at home, that means the couple will need a new child-care plan and increased costs will come with it.
Harvey, who has been an autoworker for 20 years, said it would be "kind of silly" to think that the transition to electric vehicles would happen at the flick of a switch. He said he and his wife remain optimistic about the EV market and that's why they purchased a Chevy Blazer EV just a few weeks ago.
"We're committed to moving into the future with the electrified vehicles," he said.
"I do believe it will get there eventually."
This report by The Canadian Press was first published June 19, 2025.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

READ THIS PRESS RELEASE IF YOU WERE IMPLANTED WITH MENTOR SILICONE BREAST IMPLANTS IN CANADA BETWEEN OCTOBER 19, 2006 TO OCTOBER 21, 2024 Français
READ THIS PRESS RELEASE IF YOU WERE IMPLANTED WITH MENTOR SILICONE BREAST IMPLANTS IN CANADA BETWEEN OCTOBER 19, 2006 TO OCTOBER 21, 2024 Français

Cision Canada

timean hour ago

  • Cision Canada

READ THIS PRESS RELEASE IF YOU WERE IMPLANTED WITH MENTOR SILICONE BREAST IMPLANTS IN CANADA BETWEEN OCTOBER 19, 2006 TO OCTOBER 21, 2024 Français

VANCOUVER, BC, June 27, 2025 /CNW/ - The following statement is being issued by Rice Harbut Elliott LLP regarding certification of 12 common issues in the below-noted class action: On October 21, 2024, a class action was certified by order of the B.C. Supreme Court in Bosco v. Mentor Worldwide LLC and Johnson & Johnson Inc., S.C.B.C. Action No. VLC S-190084 (the " National Class Action") relating to Mentor MemoryGel™ silicone gel-filled breast implants (" Mentor Silicone Breast Implants"). While the Class Action was started in British Columbia, it includes Canadian residents in all provinces and territories. The Class or Class Members includes all persons who were implanted with Mentor Silicone Breast Implants in Canada between October 19, 2006 to October 21, 2024 (the " Class" or "Class Members"). Certification is not a settlement or resolution of the National Class Action. It is the completion of the first major procedural step in a class action – certification of common issues and the class – that will advance towards a common issues trial, if the case is not resolved prior to trial. The National Class Action alleges that Mentor Silicone Breast Implants may cause specific connective tissue disorders and breast implant illness. While none of the allegations have been proven, the Court has certified 12 common issues that should be decided in common for all Class Members. The common issues relate to whether the Mentor Silicone Breast Implants can cause specific connective tissue disorders and/or breast implant illness and, if so, whether the Defendants breached their duty to class members in its post-market surveillance and/or monitoring of the Mentor Silicone Breast Implants with respect to those conditions, and, by extension, whether the Defendants' acts or omissions were negligent or in breach of Business Practices and Consumer Protection Act, S.B.C. 2004 and/or Competition Act, R.S.C., c. C-34 (federal). None of the claims against the Defendants have been proven. The Defendants vigorously deny all of the allegations made in the Class Action, they deny any liability, fault or wrongdoing regarding the claims, and they intend to defend the class action. If a person falls within the class definition approved by the Court, then they are automatically included in the Class and do not have to do anything to participate. If a person does not want to be part of the National Class Action, they must complete an Opt Out Form by the deadline of August 11, 2025, which can be found on Class Counsel's website at

LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC
LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC

Cision Canada

timean hour ago

  • Cision Canada

LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC

BOUCHERVILLE, QC, June 27, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (" LSL Pharma" or the " Corporation"), a Canadian integrated pharmaceutical company, today announced having secured a new $7.5 million operating line of credit (the "New Line of Credit") from Caisse Populaire Desjardins des Patriotes ("Desjardins") as well as new $10 million pari-passu term loan from BDC and Caisse Populaire Desjardins (the "Term Loan"). The New Line of Credit which is now available, represents a $4.2 million increase over the prior combined line of credit from TD Bank and Scotia Bank. The Term Loan financing expected to close on or about July 7, 2025 will be disbursed in three separate tranches. The first tranche to be disbursed on closing and serve to reimburse existing loans totalling $3.2 million plus accrued interest, as well as all outstanding Convertible Debentures listed asTSXV: representing a principal amount of $3.288 million plus accrued interest (the "Redemption"). The Redemption will be subject to TSXV approval and a formal announcement and notice to Debenture holders, as per the terms of the Debenture Indenture dated November 1, 2023, which is available under LSL Pharma's issuer profile on The second and third tranches will be used to fund capital expenditures and serve to reimburse other debts and loans. Disbursement of the second and third tranches is subject to certain conditions and is expected to be made available before the end of the current fiscal year. The New loan once fully disbursed, will help reduce the Corporation's annual debt servicing requirements and contribute to lower the Corporation's overall interest costs. Interest rate on the New Line of Credit as well as the Desjardins portion of the Term Loan will be based on Desjardins' prime rate plus 1%, which may be reduced based on financial criteria. The BDC portion of the Term Loan will be BDC's base rate plus 2.0% (the "Rate"). The Rate may be reduced by up to 2.5% should LSL Pharma meet certain financial criteria. The various portions of the New Loan will be amortized over 8 to 20 years, include a capital repayment moratorium for the first year on the BDC portion and will be subject to nominal financial covenants. "We are pleased to announce this New Financing and thank Desjardins and BDC for supporting LSL Pharma and sharing our vision, as we keep implementing organic and strategic growth initiatives" said Francois Roberge, President and Chief Executive Officer. "The New Line of Credit and Term loan will significantly increase our working capital flexibility by providing us with in excess of $6 million of additional financing not allocated to loans/debt repayments", said Luc Mainville, Executive Vice-President and Chief Financial Officer. Caution regarding forward-looking statements This press release may contain forward-looking statements as defined under applicable Canadian securities legislation. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "continue" or similar expressions. Forward-looking statements are based on a number of assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Corporation's ability to control or predict, that could cause actual results or performance to differ materially from those expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, those identified in the Corporation's filings with Canadian securities regulatory authorities, such as legislative or regulatory developments, increased competition, technological change and general economic conditions. All forward-looking statements made herein should be read in conjunction with such documents. Readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that any of the events referred to in the forward-looking statements will transpire, and if any of them do, the actual results, performance or achievements of the Corporation may differ materially from those expressed or implied by the forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. The Corporation does not undertake to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) have reviewed or accept responsibility for the adequacy or accuracy of this release. About LSL Pharma Group Inc. LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Companies forming part of LSL Pharma Group are Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc. and Dermolab Pharma Ltd. For further information, please visit our website at SOURCE Groupe LSL PHARMA INC.

FPX Nickel Announces Results of 2025 Annual General and Special Meeting
FPX Nickel Announces Results of 2025 Annual General and Special Meeting

Cision Canada

timean hour ago

  • Cision Canada

FPX Nickel Announces Results of 2025 Annual General and Special Meeting

VANCOUVER, BC, June 27, 2025 /CNW/ - FPX Nickel Corp. (TSXV: FPX) (OTCQB: FPOCF) (" FPX" or the " Company") is pleased to announce the results of its 2025 Annual General and Special Meeting held on June 26, 2025. Shareholders voted in favour of all items put forward by the Board of Directors and Management. Shareholders elected eight directors to the Company's Board, namely, Kim Baird, Peter M.D. Bradshaw, Anne Currie, James S. Gilbert, Peter J. Marshall, Andrew Osterloh, Robert B. Pease and Martin E. Turenne. The shareholders approved all other matters as proposed, including the appointment of DeVisser Gray LLP as the auditor of the Company and approval of the Company's 10% rolling share compensation plan. About FPX Nickel Corp. FPX Nickel Corp. is focused on the exploration and development of the Decar Nickel District, located in central British Columbia, and other occurrences of the same unique style of naturally occurring nickel-iron alloy mineralization known as awaruite. For more information, please view the Company's website at or contact Martin Turenne, President and CEO, at (604) 681-8600 or [email protected]. On behalf of FPX Nickel Corp. "Martin Turenne" Martin Turenne, President, CEO and Director Forward-Looking Statements Certain of the statements made and information contained herein is considered "forward-looking information" within the meaning of applicable Canadian securities laws. These statements address future events and conditions and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators. Actual results could differ from those currently projected. The Company does not assume the obligation to update any forward-looking statement. Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. SOURCE FPX Nickel Corp.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store